on Medacta Group SA (isin : CH0468525222)
Medacta Group SA Reports 14.3% Revenue Growth at Constant Currency in 1H 2024
Medacta Group SA announced a 14.3% growth in revenues at constant currency for the first half of 2024, reaching €288.6 million, compared to the same period in 2023. The EMEA region led with a 16.6% increase, followed by APAC with 12.6% and North America with 11.1% growth.
The company saw significant performance in its Knee and Shoulder business lines, with revenues increasing by 18.6% and 39.6% respectively. CEO Francesco Siccardi highlighted the company's commitment to sustainable innovation and personalized medicine during its 25th Anniversary World Tour.
Medacta continues to expand its supply chain and industrial facilities while focusing on medical education through global scientific events. The official half-year results will be released on September 25, 2024.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Medacta Group SA news